: 1. To increase acute stroke symptom knowledge among Mexican American and non-Hispanic white middle school children and their parents/ guardians. 2. To increase behavioral intent to immediately activate emergency medical services among Mexican American and non-Hispanic white middle school children and their parents/ guardians. HYPOTHESIS: A culturally sensitive school-based intervention derived from Social Cognitive Theory will improve stroke knowledge and motivation to contact emergency medical services to deliver acute stroke treatment. BACKGROUND/SIGNIFICANCE: The Food and Drug Administration approved acute stroke therapy has a three-hour time window for use from symptom onset. Delay in hospital arrival is the overwhelming reason prohibiting acute stroke therapy. Lack of immediate activation of emergency medical services is the single most important factor impeding time-dependent acute stroke therapy. Less than 5% of patients' call 9-1-1 themselves due to stroke related motor and language deficits. Family members are most likely to activate emergency medical systems. Providing knowledge and motivation to youth and their parents/guardians will greatly facilitate delivery of acute stroke therapy. Hispanic Americans are now the United States' largest minority population and Mexican Americans are the largest Hispanic American sub-group. Hispanic Americans have higher stroke incidence rates, and are particularly vulnerable to stroke at younger ages compared with non-Hispanic whites. SECONDARY AIM: To increase behavioral action to immediately activate emergency medical services among Mexican American and non-Hispanic white middle school children and their parents/ guardians. HYPOTHESIS: The intervention will not only improve intention to contact emergency medical services for acute stroke, but this action will be observed during the course of the study. SIGNIFICANCE: Stroke strikes over 700,000 United States' residents annually. Rapid paramedic transport to the emergency department is critical. Behavioral intent must be translated into action for ultimate success of the intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
1P50NS044227-01
Application #
6695805
Study Section
Special Emphasis Panel (ZNS1-SRB-K (01))
Project Start
2002-09-15
Project End
2007-08-31
Budget Start
Budget End
2003-08-31
Support Year
1
Fiscal Year
2002
Total Cost
$143,375
Indirect Cost
City
Houston
State
TX
Country
United States
Zip Code
77225
Berekashvili, Ketevan; Soomro, Jazba; Shen, Loren et al. (2018) Safety and Feasibility of Argatroban, Recombinant Tissue Plasminogen Activator, and Intra-Arterial Therapy in Stroke (ARTSS-IA Study). J Stroke Cerebrovasc Dis 27:3647-3651
Cai, Chunyan; Rahbar, Mohammad H; Hossain, Md Monir et al. (2017) A placebo-controlled Bayesian dose finding design based on continuous reassessment method with application to stroke research. Contemp Clin Trials Commun 7:11-17
Barreto, Andrew D; Ford, Gary A; Shen, Loren et al. (2017) Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke). Stroke 48:1608-1616
Ifejika, Nneka Lotea; Noser, Elizabeth Anne; Grotta, James C et al. (2016) Swipe out Stroke: Feasibility and efficacy of using a smart-phone based mobile application to improve compliance with weight loss in obese minority stroke patients and their carers. Int J Stroke 11:593-603
Lyden, Patrick; Hemmen, Thomas; Grotta, James et al. (2016) Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2). Stroke 47:2888-2895
McDonald, Mark M; Wetzel, Jeremy; Fraser, Stuart et al. (2016) Thrombelastography does not predict clinical response to rtPA for acute ischemic stroke. J Thromb Thrombolysis 41:505-10
Vahidy, F S; Rahbar, M H; Lal, A P et al. (2015) Patient refusal of thrombolytic therapy for suspected acute ischemic stroke. Int J Stroke 10:882-6
Schlick, Konrad H; Hemmen, Thomas M; Lyden, Patrick D (2015) Seizures and Meperidine: Overstated and Underutilized. Ther Hypothermia Temp Manag 5:223-7
Ifejika, Nneka L; Vahidy, Farhaan; Aramburo-Maldonado, Linda A et al. (2015) Acute Intravenous Tissue Plasminogen Activator Therapy does not Impact Community Discharge after Inpatient Rehabilitation. Int J Neurorehabil 2:
Huang, Richard S P; McDonald, Mark M; Wetzel, Jeremy S et al. (2015) Clot Strength as Measured by Thrombelastography Correlates with Platelet Reactivity in Stroke Patients. Ann Clin Lab Sci 45:301-7

Showing the most recent 10 out of 72 publications